Angelman Syndrome Latest Advances

Find the Latest Research About Angelman Syndrome

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1798 publications

Diffuse Large B-Cell Lymphoma Presenting With Superior Vena Cava Syndrome and Recurrent Pleural Effusions in a Patient With Angelman Syndrome: A Case Report.

Diffuse Large B-Cell Lymphoma Presenting With Superior Vena Cava Syndrome and Recurrent Pleural Effusions in a Patient With Angelman Syndrome: A Case Report.

Journal: Cureus
Published: June 11, 2026

Neuronal UBE3A loss engages a TNF-driven neuron-to-microglia axis that promotes synapse remodeling.

Neuronal UBE3A loss engages a TNF-driven neuron-to-microglia axis that promotes synapse remodeling.

Journal: bioRxiv : the preprint server for biology
Published: June 05, 2026

Targeting UBE3A and downstream estrogen receptor-β signaling to restore oligodendroglial homeostasis in Angelman syndrome.

Targeting UBE3A and downstream estrogen receptor-β signaling to restore oligodendroglial homeostasis in Angelman syndrome.

Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026

How I treat Angelman syndrome: an expert opinion.

How I treat Angelman syndrome: an expert opinion.

Journal: Expert opinion on pharmacotherapy
Published: June 03, 2026

Angelman syndrome with atypical presentation mimicking cerebral palsy: diagnosis and treatment challenges.

Angelman syndrome with atypical presentation mimicking cerebral palsy: diagnosis and treatment challenges.

Journal: Boletin medico del Hospital Infantil de Mexico
Published: May 25, 2026

Nonpharmacological Sleep Interventions for Children With Angelman Syndrome: A Scoping Review.

Nonpharmacological Sleep Interventions for Children With Angelman Syndrome: A Scoping Review.

Journal: The American journal of occupational therapy : official publication of the American Occupational Therapy Association
Published: May 08, 2026

Toward a Small Molecule Therapy for Angelman Syndrome: Structure-Activity Relationship Studies of 3-Aminopyrazole Phenylacetamides as Paternal Ube3a Unsilencers.

Toward a Small Molecule Therapy for Angelman Syndrome: Structure-Activity Relationship Studies of 3-Aminopyrazole Phenylacetamides as Paternal Ube3a Unsilencers.

Journal: Journal of medicinal chemistry
Published: May 08, 2026

Operant behavior is reliably impaired in a mouse model of Angelman syndrome.

Operant behavior is reliably impaired in a mouse model of Angelman syndrome.

Journal: Research square
Published: March 27, 2026

Cannabidiol corrects sleep deficits and reduces spontaneous seizures in Angelman syndrome model mice.

Cannabidiol corrects sleep deficits and reduces spontaneous seizures in Angelman syndrome model mice.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: March 25, 2026

A patient-specific induced pluripotent stem cell and neural stem cell resource for angelman syndrome with 15q11.2-q13 deletion.

A patient-specific induced pluripotent stem cell and neural stem cell resource for angelman syndrome with 15q11.2-q13 deletion.

Journal: Scientific reports
Published: February 19, 2026

SEMA6B-Related Progressive Myoclonic Epilepsy Mimicking Angelman Syndrome.

SEMA6B-Related Progressive Myoclonic Epilepsy Mimicking Angelman Syndrome.

Journal: Movement disorders clinical practice
Published: February 12, 2026

A de Novo Genome Assembly of an Angelman Syndrome Pig (sus Scrofa Domesticus) Model to Resolve SNHG14.

A de Novo Genome Assembly of an Angelman Syndrome Pig (sus Scrofa Domesticus) Model to Resolve SNHG14.

Journal: The Journal of heredity
Published: February 04, 2026
Showing 1-12 of 1,798

Last Updated: 06/30/2026